EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis

Reea P Ahola iD, Eline S Zwart, Benediktas Kurlinkus, Asif Halimi, Bengi S Yilmaz, Giulio Belfiori, Keith Roberts, Rupaly Pande, Hasan A Al-Saffar, Patrick Maisonneuve iD, Güralp O Ceyhan, Johanna Laukkarinen

BJS Open · 2024

DOI: 10.1093/bjsopen/zrae076 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift BJS Open, 2024. Verfasst von Reea P Ahola und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Gastrointestinal Surgery, Tampere University Hospital and Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Margins of Excision, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cancer Center Amsterdam Foundation, Lithuanian Gastroenterology Society, State Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The introduction of the 1 mm cut-off for resection margin according to the Leeds Pathology Protocol has transformed the concept of surgical radicality. Its impact on nodal-positive resected pancreatic ductal adenocarcinoma patients is unclear. The aim of this study was to analyse the effect of margin clearance on survival among resected, nodal-positive pancreatic ductal adenocarcinoma patients whose specimens were analysed according to the Leeds Pathology Protocol.

Methods

Data were collected retrospectively from multicentre clinical databases. Resected patients with nodal involvement were included. Overall survival and disease-free survival were analysed according to minimum reported margin clearances of 0, 0.5, 1, and 2 mm. The results are reported separately for patients who had not undergone venous resection and for patients for whom data were available regarding the superior mesenteric vein-facing margin or the vein specimen. The eighth edition of TNM classification by the AJCC was used.

Results

The study comprised 290 stage IIB patients and 215 stage III patients without venous resection. The superior mesenteric vein margin analysis comprised 127 stage IIB patients and 198 stage III patients. The different resection margin distances were not associated with overall survival and disease-free survival among patients without venous resection (P > 0.050). Receiving adjuvant therapy was associated with longer overall survival among stage IIB patients (P = 0.034) and stage III patients (P = 0.003) and with longer disease-free survival among stage III patients (P < 0.001).

Conclusions

In this study, a margin clearance greater than 1 mm showed no clear effect on overall survival in pancreatic ductal adenocarcinoma patients with nodal involvement, whereas adjuvant therapy was confirmed to be essential to ensure longer overall survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsMargins of ExcisionCarcinoma, Pancreatic DuctalHumansRetrospective StudiesMaleFemaleAgedMiddle AgedDisease-Free SurvivalNeoplasm StagingPancreatectomyLymphatic MetastasisMesenteric VeinsAdenocarcinomaAged, 80 and overAdult

Autor:innen und Institutionen

  • Department of Gastroenterology and Gastrointestinal Surgery, Tampere University Hospital and Tampere University, Tampere, Finland.
  • Department of Surgery, Amsterdam UMC, Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Clinic of Gastroenterology, Nephrourology and Surgery, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.
  • Division of Surgery, CLINITECH, Karolinska Institute, Stockholm, Sweden.
  • Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden.
  • Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.

ORCID-Profile: Reea P Ahola, Patrick Maisonneuve

Förderung

  • Cancer Center Amsterdam Foundation
  • Lithuanian Gastroenterology Society
  • State Research Funding
  • Finland and the Sigrid Jusélius Foundation
  • Italian Ministry of Health via Ricerca Corrente

Zitieren

APA

Ahola, R. P., Zwart, E. S., Kurlinkus, B., Halimi, A., Yilmaz, B. S., Belfiori, G., Roberts, K., Pande, R., Al-Saffar, H. A., Maisonneuve, P., Ceyhan, G. O., & Laukkarinen, J. (2024). Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis. BJS Open. https://doi.org/10.1093/bjsopen/zrae076

Vancouver

Ahola RP, Zwart ES, Kurlinkus B, Halimi A, Yilmaz BS, Belfiori G, et al. Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis. BJS Open. 2024. doi:10.1093/bjsopen/zrae076

BibTeX
@article{Ahola2024,
  author = {Ahola, Reea P and Zwart, Eline S and Kurlinkus, Benediktas and Halimi, Asif and Yilmaz, Bengi S and Belfiori, Giulio and Roberts, Keith and Pande, Rupaly and Al-Saffar, Hasan A and Maisonneuve, Patrick and Ceyhan, Güralp O and Laukkarinen, Johanna},
  title = {Margin clearance greater than 1 mm in nodal-positive pancreatic adenocarcinoma patients: multicentre retrospective analysis},
  journal = {BJS Open},
  year = {2024},
  doi = {10.1093/bjsopen/zrae076}
}
Kostenlos starten →